The Pay Gap Nobody Names

Every academic surgeon I know has, at some point, done the private practice math in their head and then quietly closed that tab. Today I want to actually open it, because the real numbers are more specific, and more revealing, than the vague sense most of us carry around.

73% vs 15%

Read that again slowly, because it is not the number you would expect. Academic surgery is often assumed to be the slower, more protected lane, with clinical volume traded off against teaching and research time. The data says otherwise. Academic surgeons generated 12 to 23 percent more work RVUs than non academic surgeons in every year studied, and by 2022 their practices collected 7 percent more per RVU.

Now here is the part that should actually bother you.

Total compensation for academic surgeons did not rise to match that surge in collections. The ratio of what they were paid to what they collected was 0.99 in 2010 and 0.99 in 2022, essentially flat. The hospital captured the upside. The surgeon did not.

The mechanical reason is almost administrative in its dullness, which is exactly why nobody talks about it. Only an estimated 30 to 40 percent of academic departments use academic RVU incentive plans, which reward research, teaching, and administrative work, and academic surgeon salaries tend to be fixed. You can produce more and your paycheck may not notice.

So the honest picture is not that academic surgery is a bad deal. It is that academic surgery is a specific, deliberate trade, and most surgeons never see the terms of that trade written down plainly enough to decide with open eyes whether they are making it on purpose or simply by inertia.

You are trading a meaningful percentage of lifetime earnings, often into the hundreds of thousands of dollars over a career, for protected time, teaching, research infrastructure, and a form of professional satisfaction that shows up in the survey data. That can be a genuinely good trade. It should not be an accidental one.

If you are a resident or fellow trying to decide between paths, or an attending wondering whether your current structure still makes sense, this is a conversation worth having deliberately rather than by default. AskDimitri can help you think through what you are actually optimizing for.

Think through the trade →

Nobody chooses academic surgery for the money. That is fine, and often admirable. What is not fine is not knowing the actual size of what you are giving up, because a trade you cannot name is a trade you cannot defend, to yourself or to anyone else.

Editor's note: in October 2026 the figures in this letter were checked against the sources listed below, and the text was corrected where the letter as sent differed from them.